Showing results (1-10 of 4,009) with videos related to
Sort By:
Pageof 401
Regulatory Toxicology and Pharmacology : RTP|September 1, 1988
Postnatal testing--a regulator's viewpointS J GrieveThe New Zealand Medical Journal|August 24, 1977
Distribution of various coronary risk factors in an urban general practiceR J GrievePharmacology & Therapeutics|March 26, 2009
Significance of peroxisome proliferator-activated receptors in the cardiovascular system in health and diseaseEmma Robinson, David J GrievePeptides|February 8, 2018
Biochemical properties and biological actions of obestatin and its relevence in type 2 diabetesBrian D Green, David J GrieveBritish Journal of Pharmacology|October 19, 2017
New insights into cardiotoxicity caused by chemotherapeutic agentsDavid J Grieve, Sean M DavidsonThe Journal of Pharmacy and Pharmacology|September 1, 1979
The rapid development of functional tolerance to ethanol by miceS J Grieve, J M LittletonClinical Oncology (Royal College of Radiologists (Great Britain))|January 8, 2010
A study of medical intervention in routine breast cancer follow-upQ Ghafoor, P Sanghera, R J GrieveDiabetic Medicine : a Journal of the British Diabetic Association|November 1, 2019
The influence of vestibular stimulation on metabolism and body compositionJ McKeown, P D McGeoch, D J GrieveClinical Science (London, England : 1979)|May 6, 2017
Are targeted therapies for diabetic cardiomyopathy on the horizon?Mitchel Tate, David J Grieve, Rebecca H RitchieBritish Journal of Pharmacology|August 18, 2009
Emerging cardiovascular actions of the incretin hormone glucagon-like peptide-1: potential therapeutic benefits beyond glycaemic control?David J Grieve, Roslyn S Cassidy, Brian D GreenPageof 401